Loukas Kontovinis

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers

Loukas Kontovinis, Konstantinos Papazisis, Panagiota Touplikioti et al. · BMC Cancer · 2009 · 90 citations · Full text

Medicine, Oncology, Pharmacology +17

Prognostic Significance of Low HER2 Expression in Patients With Early Hormone Receptor Positive Breast Cancer

George Douganiotis, Loukas Kontovinis, Efrosini Markopoulou et al. · Cancer Diagnosis & Prognosis · 2022 · 39 citations · Full text

Medicine, Oncology, Pathology +15

Erythropoiesis stimulating agents are associated with reduced survival in patients with multiple myeloma

Eirini Katodritou, Evgenia Verrou, Christina Hadjiaggelidou et al. · American Journal of Hematology · 2008 · 31 citations

Medicine, Hematology, Oncology +11

Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model

Aristotelis Bamias, Alexandra Karadimou, Sofia Lampaki et al. · BMC Cancer · 2010 · 29 citations · Full text

Medicine, Oncology, Surgery +14

Sequential treatment with sorafenib and sunitinib in metastatic renal cell carcinoma: clinical outcomes from a retrospective clinical study

Loukas Kontovinis, Κonstantinos Laschos, Alexandra Karadimou et al. · Medical Oncology · 2011 · 18 citations

Medicine, Oncology, Pharmacotherapy +15